<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:hpo ids='HP_0011010'>Chronic</z:hpo> <z:hpo ids='HP_0000704'>periodontitis</z:hpo> (CP) is a <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> associated with elevations of several inflammatory and cardiac markers </plain></SENT>
<SENT sid="1" pm="."><plain>Studies implicated CP as one of the etiologies in <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> (CHD) </plain></SENT>
<SENT sid="2" pm="."><plain>Cardiotoxicity is a major complication of anticancer drugs, including <z:chebi fb="0" ids="48120">anthracyclines</z:chebi> and <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi> (5FU) </plain></SENT>
<SENT sid="3" pm="."><plain>The most severe cardiac complications are <z:hpo ids='HP_0001635'>heart failure</z:hpo>, <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> and <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> (CHD) </plain></SENT>
<SENT sid="4" pm="."><plain>In this study, we compared the level of inflammatory factors and cardiac markers between <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0000704'>periodontitis</z:hpo> patients and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients receiving chemotherapy </plain></SENT>
<SENT sid="5" pm="."><plain>METHODS: 108 blood samples of periodontally healthy subjects were obtained on random from Hong Kong Red Cross, and these represented the controlled population </plain></SENT>
<SENT sid="6" pm="."><plain>Forty-four patients diagnosed with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0000704'>periodontitis</z:hpo> were recruited from the West China Hospital of Stomatology, Sichuan University </plain></SENT>
<SENT sid="7" pm="."><plain>They have received scaling and root planning with mean pocket depths of 6.05 mm </plain></SENT>
<SENT sid="8" pm="."><plain>Thirty <z:hpo ids='HP_0003002'>breast cancer</z:hpo> patients diagnosed with invasive ductal <z:mp ids='MP_0002038'>carcinoma</z:mp> from UNIMED Medical Institute, Hong Kong gave consent to participate in this study </plain></SENT>
<SENT sid="9" pm="."><plain>They received 4 cycles of 500mg/m2 <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi>, 75 mg/m2 epirubicin and 500mg/m2 cyclophosphamide at a 3-week interval between each cycle </plain></SENT>
<SENT sid="10" pm="."><plain>Peripheral venous blood from each group was taken for measurement of blood cells, inflammatory marker (P-selectin, high sensitvity C-reactive protein) and cardiac markers (troponin T; troponin I; N-terminal pro brain natriuretic <z:chebi fb="7" ids="16670">peptide</z:chebi> (Nt-proBNP) and <z:chebi fb="4" ids="24996">Lactate</z:chebi> dehydrogenase (LDH) </plain></SENT>
<SENT sid="11" pm="."><plain>RESULTS: The lymphocyte count was higher (p &lt; 0.05) in <z:hpo ids='HP_0000704'>periodontitis</z:hpo> patients than the other two groups, and more neutrophils (p &lt; 0.05) were seen in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients receiving chemotherapy </plain></SENT>
<SENT sid="12" pm="."><plain>The two test groups demonstrated higher levels (p &lt; 0.01) of inflammatory and cardiac markers than the control group </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSIONS: The elevated cardiac markers found in <z:hpo ids='HP_0000704'>periodontitis</z:hpo> patients suggested that they may carry potential risks in developing cardiac lesions </plain></SENT>
<SENT sid="14" pm="."><plain>Troponin T, troponin I, pro-BNP, LDH and high sensitvity C-reactive protein may be used as markers to monitor cardiac lesions in <z:hpo ids='HP_0011010'>chronic</z:hpo> inflammatory patients </plain></SENT>
</text></document>